A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655
ZOLL Medical Corporation
+1 (978) 421-9637
ZOLL MEDICAL NAMED ONE OF AMERICA’S MOST TRUSTWORTHY COMPANIES FOR 3rd CONSECUTIVE YEAR
One of Only Ten Companies on Forbes Top 100 List for Three Years
April 22, 2009—CHELMSFORD, Mass.—ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has been named one of America’s 100 Most Trustworthy Companies by Forbes for the third consecutive year.
Of the approximately 12,000 public companies reviewed to compile the list, ZOLL was one of the six medical companies listed on the Top 100. ZOLL also received special recognition as one of only 10 companies that has made the list for all three years it has been published.
This is the third year that Audit Integrity has provided Forbes.com with a list of 100 American companies that, by its assessment, have the highest Accounting and Governance Risk (AGR) ratings, which evidence clear financial reporting and transparent corporate governance. According to Audit Integrity, risk scores are derived from statistical analysis, which incorporates over 100 metrics that together provide a comprehensive view of management behavior and motivation.
In the independent firm’s judgment, the top 100 companies have a low incidence of risk factors in accounting, governance and high risk events, and “stand in stark contrast with the companies fraught with scandal, fraud and corporate excesses in today’s headlines.” The full report may be viewed at www.forbes.com/2009/04/02/trustworthy-audit-integrity-leadership-aig.html or downloaded at www.auditintegrity.com.
“We are honored that Forbes has recognized ZOLL for having the highest standards of corporate integrity for the third consecutive year,” said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL. “This award is a great credit to ZOLL’s shareholders, employees and customers, who support and share our strong commitment to providing clinical advances in resuscitation.”
ZOLL’s innovative resuscitation products for treating sudden cardiac arrest, the world’s number one cause of unexpected death, have been instrumental in improving the quality of CPR and survival rates. Examples include:
- AutoPulse®, an innovative non-invasive cardiac support pump that automates chest compressions;
- LifeVest®, the world’s first and only wearable external defibrillator;
- Defibrillators featuring Real CPR Help®, auditory and visual real-time feedback on the rate and depth of chest compressions to encourage high-quality CPR to maximize blood flow;
- See-Thru CPR®, a unique technology that helps to minimize interruptions during CPR—one of the key recommendations of the American Heart Association’s Guidelines for Advanced Life Support;
- Resuscitation products from data management to power infusion and hypothermia.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, hypothermia, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. During 2008 ZOLL marked the 25th anniversary of the company’s resuscitation product development. For more information, visit www.zoll.com.
Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on February 6, 2009. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.
Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AutoPulse, LifeVest, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation.